Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth.
about
Non-natural and photo-reactive amino acids as biochemical probes of immune functionThe zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cellsAnalysis of the tumour suppressor genes, FHIT and WT-1, and the tumour rejection genes, BAGE, GAGE-1/2, HAGE, MAGE-1, and MAGE-3, in benign and malignant neoplasms of the salivary glandsAdvances in inducing adaptive immunity using cell-based cancer vaccines: Clinical applications in pancreatic cancerDendritic cell-based cancer immunotherapy for colorectal cancerAberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast CancerActive specific immunotherapy targeting the Wilms' tumor protein 1 (WT1) for patients with hematological malignancies and solid tumors: lessons from early clinical trialsWT1 gene expression as a prognostic marker in advanced serous epithelial ovarian carcinoma: an immunohistochemical study.Re-adapting T cells for cancer therapy: from mouse models to clinical trials.A TCR-mimic antibody to WT1 bypasses tyrosine kinase inhibitor resistance in human BCR-ABL+ leukemiasImmunotherapy for leukemia targeting the Wilms' tumor gene.Wilms tumor gene (WT1) expression as a panleukemic marker.Cancer immunotherapy targeting WT1 protein.Wilms' tumor 1 (WT1) expression and prognosis in solid cancer patients: a systematic review and meta-analysis.Wilms' tumor gene 1 regulates p63 and promotes cell proliferation in squamous cell carcinoma of the head and neckAssociation between WT1 polymorphisms and susceptibility to breast cancer: results from a case-control study in a southwestern Chinese populationIdentification of a Novel C-Terminal Truncated WT1 Isoform with Antagonistic Effects against Major WT1 Isoforms.Wilms' tumor 1 silencing decreases the viability and chemoresistance of glioblastoma cells in vitro: a potential role for IGF-1R de-repressionWT1 gene transcript assay for relapse in acute leukemia after transplantation.Cancer immunotherapy targeting Wilms' tumor gene WT1 product.Antigen-specific cellular immunotherapy of leukemia.Dendritic Cell-Based Adjuvant Vaccination Targeting Wilms' Tumor 1 in Patients with Advanced Colorectal Cancer.Increased expression of tumor-associated antigens in pediatric and adult ependymomas: implication for vaccine therapyInduction of Wilms' tumor protein (WT1)-specific antitumor immunity using a truncated WT1-expressing adenovirus vaccineTransferred WT1-reactive CD8+ T cells can mediate antileukemic activity and persist in post-transplant patients.Peptide Based Vaccine Approaches for Cancer-A Novel Approach Using a WT-1 Synthetic Long Peptide and the IRX-2 Immunomodulatory RegimenDiagnostic utility of Wilms' tumour-1 protein (WT-1) immunostaining in paediatric renal tumoursTranscriptional repression of tumor suppressor CDC73, encoding an RNA polymerase II interactor, by Wilms tumor 1 protein (WT1) promotes cell proliferation: implication for cancer therapeutics.A novel cell-penetrating peptide derived from WT1 enhances p53 activity, induces cell senescence and displays antimelanoma activity in xeno- and syngeneic systems.Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression.Adenovirus vaccine immunotherapy targeting WT1-expressing tumors.WT1 (Wilms' tumor gene 1): biology and cancer immunotherapy.WT1 peptide vaccinations induce CD4 and CD8 T cell immune responses in patients with mesothelioma and non-small cell lung cancer.T cell-based targeted immunotherapies for patients with multiple myeloma.Quantitative promoter methylation differentiates carcinoma ex pleomorphic adenoma from pleomorphic salivary adenoma.Tumor Vaccines for Malignant Gliomas.Expression of Wilms' tumor 1 (WT1) in oral squamous cell carcinoma.WT1 gene silencing by aerosol delivery of PEI-RNAi complexes inhibits B16-F10 lung metastases growth.Enhancement of lytic activity of leukemic cells by CD8+ cytotoxic T lymphocytes generated against a WT1 peptide analogue.Identification of a WT1 protein-derived peptide, WT1, as a HLA-A 0206-restricted, WT1-specific CTL epitope.
P2860
Q21144124-D36F39FB-A8D1-4ACE-9B7F-F39213C3EEFFQ21195233-D51D4F8F-E930-4232-9195-649E02785F5FQ24535522-54578968-1AC5-48AB-B730-5D1839A2911DQ26749451-8B0FEFA5-9648-4E66-BF8E-BB09A4B81FD8Q26751339-A1D3312F-64CB-4774-B264-2AA05DF56DAFQ26773907-E6C7F6CE-916F-41AC-8CCA-C4FCFE9C0CD2Q27026836-D5EA361A-1E67-48B6-8062-95B28DD8F3C6Q33239524-3739164E-B3A8-4119-9B00-44EE18CEDBB1Q33588711-5285D593-AA92-4E86-BF25-2C760B14FBB4Q33714727-968389E6-F478-41B4-A1C8-DBE89DA41A42Q34431555-D7277C2A-EAE8-4CE6-A047-A871ABD27510Q34820008-54147D2E-110D-44D0-BBFB-7AC433882A1FQ34820068-3922C364-ECF6-48FB-8B4E-CB5C8726C63AQ35157134-F4E88EA4-8DA1-4F06-84B0-97D3C401A842Q35575285-1DDD2CB5-F4AB-45F4-9EE5-AF0C24FDE079Q35666497-D8C39E49-EC08-4980-BD4C-7F7EC7D3A650Q35668616-B0C29529-7425-41F2-AC32-2E94472CCE4AQ35751162-4AAAADF0-F30C-4F7E-AD52-1BBFCDECEA59Q35821007-D552CF17-2E75-49C8-93D2-961AA25C06FBQ36238704-D0CA62AF-110B-4E62-AE4B-A6ED5FB9B54CQ36240201-CFB6C1A6-B570-41DF-96FE-58957362018AQ36409532-7F53A403-DF15-4809-BA42-2273FA26166DQ36536409-1009C516-9155-409D-9C60-8D743CCE8931Q36781571-4356CFDA-D7FF-48AD-99DC-EB7083F34F9CQ36919619-35668829-1E55-4373-B3B1-04EE98D29C5FQ37148167-190017E9-1981-4E3F-9D9B-F1EBAFA1A25EQ37367712-C0B1304A-F06B-47BD-BC02-110B4F8C25E3Q37459352-9514C9F0-219B-431C-A9E9-C7EF2F3B1266Q37535193-9987BF31-A634-4FF1-991F-17F0F32E7413Q37535549-0966FA7E-9A1E-4FF3-A025-A22535E39B9AQ37727967-11F9B4E8-05CB-41FD-9465-FFFB38611B07Q37731720-1B94072F-7779-404A-9F8D-F4CAD761E8C2Q37731754-BEAE0B0C-DA9E-4F77-9AFF-382521AA84E4Q38246639-0BC4F432-5A85-4D90-B45D-0DE26D3D4510Q38413820-F82F3221-99EA-42C1-9D24-9D8FEFDD1434Q39228039-43C5CCF4-C26A-409B-AA4C-0E6CDF0DEA22Q39336282-5A2B4E99-E2A3-4FB1-BEE5-56B4F06172AFQ39848258-A4D31AC0-4FD4-487B-9CAA-1C5009A213CFQ39886839-1C373BC6-C0CA-4D45-BBC8-11B40A20DA97Q39904111-0C9F8181-1B38-4482-B4C5-084B87B6DB39
P2860
Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Expression of the Wilms' tumor ...... olvement in tumor cell growth.
@en
type
label
Expression of the Wilms' tumor ...... olvement in tumor cell growth.
@en
prefLabel
Expression of the Wilms' tumor ...... olvement in tumor cell growth.
@en
P2093
P2860
P1476
Expression of the Wilms' tumor ...... olvement in tumor cell growth.
@en
P2093
H Sugiyama
M Kawakami
T Kishimoto
T Tatekawa
P2860
P304
P356
10.1111/J.1349-7006.1999.TB00733.X
P577
1999-02-01T00:00:00Z